Drug intelligence / Profile preview

abamectin + fenpyroximate

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Abamectin + fenpyroximate is a combination pesticide product used primarily in agriculture and pest control. Abamectin is a macrocyclic lactone derived from the fermentation of Streptomyces avermitilis, acting as a broad-spectrum antiparasitic and insecticide/acaricide. Its mechanism involves binding to glutamate-gated chloride channels in nerve and muscle cells of invertebrates, leading to paralysis and death by increasing chloride ion influx. Fenpyroximate is an acaricide belonging to the pyrazole class; it acts as a mitochondrial electron transport inhibitor (METI), specifically inhibiting complex I (NADH-coenzyme Q reductase) in the mitochondrial respiratory chain, resulting in energy depletion and death of target pests. The combination targets mites, leafminers, aphids, thrips, whiteflies, nematodes, and other agricultural pests resistant to single-agent treatments. This mixture can be formulated for foliar application or incorporated into substrates such as mosquito nets or wall linings for vector control[1][2][6].

02

Targets

GluCl (Glutamate-gated chloride channel)ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on abamectin + fenpyroximate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on abamectin + fenpyroximate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call